Shareholder Class Action Investigation
Abacus Global Management, Inc. NYSE: ABX
Henzel Law is investigating a potential shareholder class action against Abacus Global Management over its accounting for transactions with related-party investment funds and for credits granted to limited partners of funds it advises, after the company delayed its third-quarter report and the stock fell sharply on November 17, 2026.
← Current Cases · SPAC-Warrant Cases · Under Investigation · Case Archive
- Status
- Investigating — no lawsuit filed
- Estimated investigation period
- June 10, 2025 to November 17, 2026
- Ticker
- NYSE: ABX
What we’re investigating
Abacus Global Management, Inc. (NYSE: ABX) is a Delaware company headquartered in Orlando, Florida that buys, services and manages portfolios of life insurance policies and advises private investment funds that invest in the same asset class. It was formerly known as Abacus Life, Inc. and traded on Nasdaq under the symbol ABL before transferring its listing to the New York Stock Exchange, where it has traded under the symbol ABX since December 30, 2025.
Henzel Law is investigating whether Abacus and certain of its officers made materially false or misleading statements, or omitted material facts, about how the company accounted for transactions with the related-party investment funds it advises, about the credits it granted to limited partners of those funds, and about the effectiveness of its internal control over financial reporting. No lawsuit has been filed. This page describes an investigation.
The November 17, 2026 filing
Before the market opened on November 17, 2026, Abacus filed a Form 12b-25 notification stating that it could not timely file its quarterly report for the quarter ended September 30, 2026. The filing stated that the company was evaluating the accounting for credits granted to limited partners of certain private funds it advises beginning in the second quarter of 2025, and the accounting for transactions between the company and those related-party funds.
According to that filing, the company will assess whether corrections to previously issued financial statements are required, “potentially dating back to June 30, 2025,” and the reassessment “may result in a conclusion that the Company’s disclosure controls and procedures and internal control over financial reporting were not effective.” The filing stated that the company was unable to estimate the extent of any significant changes, and that the evaluation could result in a significant change in asset management revenue, related party, and related party payables. It also indicated that the possible changes extend to the third-quarter 2026 results the company had furnished on Form 8-K twelve days earlier, on November 5, 2026.
On this news, Abacus’s stock price fell sharply. The shares closed at $8.65 on November 16, 2026 and traded as low as $5.39 on November 17, 2026, a decline of $3.26 per share, or approximately 37.7%, from the prior close.
What the company had said before
Abacus’s related-party fund transactions had drawn public criticism well before the November 2026 filing. In June 2025, a short-seller report questioned the company’s valuation methodology and its related-party dealings. The company responded publicly on June 10, 2025 with a press release stating that an independent third-party actuarial firm it had retained had concurred with the company’s prior portfolio valuation, that its balance sheet valuation model estimated fair value “[i]n accordance with U.S. GAAP,” and that its auditor had “affirmed our mark-to-market valuation approach.”
In the periods that followed, the company continued to report related-party revenue and balances as ordinary course items. The investigation is examining whether those public statements, and the related-party disclosures in the company’s periodic reports from mid-2025 forward, were accurate in light of the accounting review the company announced on November 17, 2026.
What the investigation is examining
Whether the company’s financial statements for periods beginning on or after June 30, 2025 accurately reported asset management revenue from related parties, related-party receivables and related-party payables; whether the credits granted to limited partners of the funds the company advises, beginning in the second quarter of 2025, were accounted for and disclosed correctly; whether the company’s public statements about the independence of its valuation, its compliance with generally accepted accounting principles and the pricing of its related-party transactions were accurate when made; whether the company’s disclosure controls and procedures and internal control over financial reporting were effective during the period under review; and whether and when the company’s officers and directors knew of the accounting issues now under review.
The company has not announced a restatement, and it has not concluded that its internal controls were ineffective. Its November 17, 2026 filing describes a review whose outcome is not yet known.
Who this may affect
Henzel Law is interested in hearing from individual shareholders who bought Abacus Global Management (ABX) stock during the period under review and lost money, and from long-term shareholders who still hold their shares. We are not seeking institutional investors. If you bought shares and lost money, or if you have held shares for a long period and want the conduct described above looked into on the company’s behalf, we would like to hear from you. There is no charge for a case review and no obligation.
Free Case Evaluation
Tell us about your Abacus Global Management (ABX) holdings. If you do not know every detail, send what you have.
Please check the following before sending:
General enquiry
Have a question about this investigation that isn't covered above? Send a message and we will get back to you.